Stroke and CPAP Outcome Study 3 Randomized Controlled Trial

NARecruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

January 15, 2025

Primary Completion Date

April 30, 2028

Study Completion Date

May 31, 2028

Conditions
Stroke PatientsCPAPOSA - Obstructive Sleep Apnea
Interventions
DEVICE

CPAP device

Eligible participants with OSA will be started on automatically-adjusting CPAP.

BEHAVIORAL

CPAP technical support

Trained personnel will conduct mask selection and fitting, provide continual troubleshooting, and train participants on CPAP.

BEHAVIORAL

Phone follow-up for adherence feedback and self-management skills

The research coordinator will call participants approximately monthly to provide any needed support.

BEHAVIORAL

myAir

Study personnel will assist participants in registering for and using the myAir (ResMed) self-tracking app. This app also provides a library of how-to videos and provides email updates to participants.

BEHAVIORAL

Tailored messages

Tailored text messages will be sent to participants. Two-way texting messaging will also be available between the study team and participants.

BEHAVIORAL

Written Materials

A binder of written educational materials will be provided to participants.

BEHAVIORAL

Motivational Enhancement Therapy (MET)

A trained sleep coach will conduct up to 5 MET sessions with participants and 2 sessions with a CPAP partner during the study time period.

Trial Locations (2)

90242

NOT_YET_RECRUITING

Rancho Research Institute, Downey

98104

RECRUITING

University of Washington - Harborview Medical Center, Seattle

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Washington

OTHER